Flow Imaging Microscopy combined with Light Obscuration Capabilities

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEPT OF COMMERCE NIST

Contract Value

Not provided

Codes & Classification
Solicitation Number

1333ND26QNB640309

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing

Classification Code

6630

Additional Details
Set Aside

None

Place of Performance

Gaithersburg, Maryland, UNITED STATES

SourceSAM
The National Institute of Standards and Technology (NIST), a bureau within the U.S. Department of Commerce, has issued a combined synopsis/solicitation for the procurement of a flow imaging instrument with integrated light obscuration capabilities. This acquisition is managed by the Bioprocess Measurements Group, located at NIST’s Gaithersburg, Maryland campus. The group is dedicated to advancing measurement science and establishing standards for the robust characterization of biologically or synthetically derived particles, which are critical in the biomanufacturing industry. The primary objective of this procurement is to obtain a state-of-the-art instrument that combines flow imaging microscopy with light obscuration functionalities. This dual-capability system is essential for the detailed characterization of particles in drug products, a requirement driven by stringent regulatory guidelines. The new instrument will replace two outdated and unsupported systems currently in use at NIST, thereby enhancing data comparability and facilitating collaboration with industry partners who rely on similar, modern technologies. The scope of the contract includes not only the delivery and installation of the instrument but also a service agreement with option periods, as clarified in Amendment 0001 to the solicitation. This amendment also extends the due date for offers to September 4, 2026, and provides an updated Statement of Work and revised terms and conditions to reflect the inclusion of option years for ongoing service and support. Key requirements for this procurement include: - Provision of a flow imaging instrument with integrated light obscuration capabilities, suitable for the characterization of biologically or synthetically derived particles in accordance with current industry standards. - Replacement of legacy systems to ensure alignment with instruments commonly used in the biomanufacturing sector, thereby supporting regulatory compliance and enhancing collaborative research. - A comprehensive service agreement with clearly defined option periods to ensure continued operational reliability and technical support over the contract lifecycle. The procurement is classified under NAICS code 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing) and Product Service Code 6630. The place of performance is Gaithersburg, Maryland, USA. Interested contractors should note that this is a federal procurement managed by the Department of Commerce, NIST. The primary point of contact for this opportunity is Rene D. Edwards ([email protected], 301-975-6107), with Robert Singman ([email protected], 301-975-6388) serving as the secondary contact. The solicitation is currently active, with all relevant documents and amendments available via the official SAM.gov opportunity listing (Opportunity ID: ee9bc9b951144d8ca405471af6d6fca6). Contractors are encouraged to review the updated Statement of Work and terms and conditions, as well as all attachments, to ensure their proposals fully address the technical and service requirements outlined by NIST. This opportunity is particularly well-suited for manufacturers and suppliers with expertise in advanced particle characterization instrumentation and a proven track record of supporting complex laboratory equipment in regulated environments. The inclusion of option years for service underscores NIST’s commitment to maintaining the instrument’s performance and reliability throughout its operational life.
Documents8